In this three-month follow-up study, researchers examined discharged patients who had received human umbilical cord-MSC therapy to assess the safety of this therapy and the health-related quality of life of these patients.
[Stem Cells and Development]
6445218
{6445218:8YIQ5MS3}
apa
50
1
163086
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-8bcc9fda4c6a80fc8e0e3998eaf8bd62%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%228YIQ5MS3%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Feng%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFeng%2C%20G.%2C%20Shi%2C%20L.%2C%20Huang%2C%20T.%2C%20Ji%2C%20N.%2C%20Zheng%2C%20Y.%2C%20Lin%2C%20H.%2C%20Niu%2C%20C.%2C%20Wang%2C%20Y.%2C%20Li%2C%20R.%2C%20Huang%2C%20M.%2C%20Chen%2C%20X.%2C%20Shu%2C%20L.%2C%20Wu%2C%20M.%2C%20Deng%2C%20K.%2C%20Wei%2C%20J.%2C%20Wang%2C%20X.%2C%20Cao%2C%20Y.%2C%20%26amp%3B%20Yan%2C%20J.%20%282021%29.%20Human%20umbilical%20cord%20mesenchymal%20stromal%20cell%20treatment%20of%20severe%20COVID-19%20patients%3A%20a%20three-month%20follow-up%20study%20following%20hospital%20discharge.%20%3Ci%3EStem%20Cells%20and%20Development%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1089%5C%2Fscd.2021.0015%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1089%5C%2Fscd.2021.0015%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3D8YIQ5MS3%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Human%20umbilical%20cord%20mesenchymal%20stromal%20cell%20treatment%20of%20severe%20COVID-19%20patients%3A%20a%20three-month%20follow-up%20study%20following%20hospital%20discharge%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ganzhu%22%2C%22lastName%22%3A%22Feng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lei%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tingrong%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ningfei%22%2C%22lastName%22%3A%22Ji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22You%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huan%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changming%22%2C%22lastName%22%3A%22Niu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruyou%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mao%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaolin%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lei%22%2C%22lastName%22%3A%22Shu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mingjing%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaili%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xueli%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiaxin%22%2C%22lastName%22%3A%22Yan%22%7D%5D%2C%22abstractNote%22%3A%22Previously%2C%20we%20demonstrated%20the%20therapeutic%20effects%20of%20human%20umbilical%20cord%20mesenchymal%20stromal%20cells%20%28hUC-MSCs%29%20in%20severe%20coronavirus%20disease%202019%20%28COVID-19%29%20patients.%20In%20this%20three-month%20follow-up%20study%2C%20we%20examined%20discharged%20patients%20who%20had%20received%20hUC-MSC%20therapy%20to%20assess%20the%20safety%20of%20this%20therapy%20and%20the%20health-related%20quality%20of%20life%20%28HRQL%29%20of%20these%20patients.%20The%20follow-up%20cohort%20consisted%20of%2028%20discharged%20severe%20COVID-19%20patients%20who%20received%20either%20the%20standard%20treatment%20%28the%20control%20group%29%20or%20the%20standard%20treatment%20plus%20hUC-MSC%20therapy.%20We%20examined%20liver%20function%2C%20kidney%20function%2C%20pulmonary%20function%2C%20coagulation%2C%20tumor%20markers%2C%20and%20vision.%20We%20also%20conducted%20electrocardiography%20%28ECG%29%20analysis%2C%20let%20the%20patients%20answer%20the%20St.%20George%5Cu2019s%20Respiratory%20Questionnaire%20%28SGRQ%29%2C%20and%20performed%20computed%20tomography%20%28CT%29%20imaging%20for%20assessing%20the%20lung%20changes.%20No%20obvious%20adverse%20effects%20were%20observed%20in%20the%20hUC-MSC%20group%20after%20three%20months.%20Measurements%20of%20blood%20routine%20index%2C%20C-reactive%20protein%20and%20procalcitonin%2C%20liver%20and%20kidney%20function%2C%20coagulation%2C%20ECG%2C%20tumor%20markers%2C%20and%20vision%20were%20almost%20within%20the%20normal%20ranges%20in%20both%20the%20treatment%20and%20control%20groups.%20Forced%20expiratory%20volumes%20in%201%20s%20%28FEV1%29%20%28%25%20of%20predicted%29%20were%2071.88%5Cu00b18.46%25%20and%2059.45%5Cu00b127.45%25%20in%20the%20hUC-MSC%20and%20control%20groups%20%28P%3C0.01%29%2C%20respectively%2C%20and%20FEV1%5C%2Fforced%20vital%20capacity%20%28FEV1%5C%2FFVC%29%20ratios%20were%2079.95%5Cu00b18.00%25%20and%2058.97%5Cu00b119.16%25%20in%20the%20hUC-MSC%20and%20control%20groups%2C%20respectively%20%28P%3C0.05%29.%20SGRQ%20scores%20were%20lower%20in%20the%20hUC-MSC%20group%20than%20in%20the%20control%20group%20%2815.25%5Cu00b13.69%20vs.%2031.9%5Cu00b18.78%2C%20P%3C0.05%29.%20The%20rate%20of%20wheezing%20in%20the%20hUC-MSC%20group%20was%20also%20significantly%20lower%20than%20that%20in%20the%20control%20group%20%2837.5%25%20vs.%2075%25%2C%20P%3C0.05%29.%20There%20were%20no%20significant%20differences%20in%20CT%20scores%20between%20the%20two%20groups%20%280.60%5Cu00b10.88%20vs.%201.00%5Cu00b11.31%2C%20P%3D0.917%29.%20Overall%2C%20the%20intravenous%20transplantation%20of%20hUC-MSCs%20accelerated%20partial%20pulmonary%20function%20recovery%20and%20improved%20HRQL%2C%20indicating%20the%20relatively%20safety%20and%20preliminary%20efficacy%20of%20this%20treatment%20for%20patients%20with%20severe%20COVID-19.%22%2C%22date%22%3A%22May%2027%2C%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1089%5C%2Fscd.2021.0015%22%2C%22ISSN%22%3A%221547-3287%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.liebertpub.com%5C%2Fdoi%5C%2F10.1089%5C%2Fscd.2021.0015%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-03T23%3A12%3A41Z%22%7D%7D%5D%7D
Feng, G., Shi, L., Huang, T., Ji, N., Zheng, Y., Lin, H., Niu, C., Wang, Y., Li, R., Huang, M., Chen, X., Shu, L., Wu, M., Deng, K., Wei, J., Wang, X., Cao, Y., & Yan, J. (2021). Human umbilical cord mesenchymal stromal cell treatment of severe COVID-19 patients: a three-month follow-up study following hospital discharge. Stem Cells and Development. https://doi.org/10.1089/scd.2021.0015 Cite
